SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.66+2.8%Jan 30 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (9044)3/9/1999 6:35:00 PM
From: Chris Boylan  Read Replies (1) of 17367
 
I sorry but I didn't understand part of your post. Could you
explain what you meant with the snippets below:

From message from Cacaito:
I will not like this from a Market point of view (it will go to $0.5 anyway). for the
patients any good result is good.

And if bpi has a marginal improvement in survivability it could also increase the
amputations (the one who will die has more chances for lost of limbs),and will
complicate the matter anyway, or $0.5 as per the Street.
< I don't get the $0.5 as per the street bit>

Xoma will make it or brake it. No room for the faint here, Unless one is like Robert
S and justifiably wait for the FDA approval
<What is the Robert S bit?>

Heartily agree with the make it or break it thought by the way.
It's just that when I bought into xoma I thought it was a much
better bet.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext